Alpha-tomatine activates cell cycle checkpoints in the absence of DNA damage in human leukemic MOLT-4 cells

Journal of Applied Biomedicine

Volumn 11, Issue 2, 2013, Pages 93-103

  Kúdelová, Jana ^a   Seifrtová, Martina ^a   Suchá, Lenka ^a   Tomšík, Pavel ^a   Havelek, Radim ^a   Řezáčová, Martina ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Alpha tomatine; DNA damage; Leukemia; P53; PUMA

Indexed keywords

CASPASE 9; CHECKPOINT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1A; MITOXANTRONE; PROPIDIUM IODIDE; PROTEIN P53; PUMA PROTEIN; TOMATINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOSTASIS; DNA DAMAGE; DNA FRAGMENTATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LEUKEMIA CELL; TOMATO; WESTERN BLOTTING;

EID: 84874217473     PISSN: 1214021X     EISSN: 12140287     Source Type: Journal    
DOI: 10.2478/v10136-012-0033-8     Document Type: Article

References (36)

1. Bai L, Zhu WG. P53: Structure, unction and therapeutic applications. J. Cancer Mol. 2: 141-153, 2006.
2. Bartek J, Lukas J. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell. 3: 421-429, 2003.
3. Berger J. The age of biomedicine: current trends in traditional subjects. J Appl Biomed 9: 57-61, 2011.
4. Bergers WW, Alink GM. Toxic effect of the glycoalkaloids solanine and tomatine on cultured neonatal rat heart cells. Toxicol Lett. 6: 29-32, 1980.
5. Bogner C, Leber B, Andrews DW. Apoptosis: embedded in membranes. Curr Opin Cell Biol. 22: 845-851, 2010.
6. Calini V, Urani C, Camatini M. Comet assay evaluation of DNA single-and double-strand breaks induction and repair in C3H10T1/2 cells. Cell Biol Toxicol. 18: 369-379, 2002.
7. Cazzalini O, Scovassi AI, Savio M, Stivala LA, Prosperi E. Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response. Mutat Res. 704: 12-20, 2010.
8. Chao MW, Chen CH, Chang YL, Teng CM, Pan SL. α-Tomatine-Mediated Anti-Cancer Activity In Vitro and In Vivo through Cell Cycle-and Caspase-Independent Pathways. PLoS One. 7: e44093, 2012.
9. Chiu FL, Lin JK. Tomatidine inhibits iNOS and COX-2 through suppression of NF-kappaB and JNK pathways in LPS-stimulated mouse macrophages. FEBS Lett. 582: 2407-2412, 2008.
10. Choi SH, Ahn JB, Kozukue N, Kim HJ, Nishitani Y, Zhang L, Mizuno M, Levin CE, Friedman M. Structure-activity relationships of α-, β (1)-, γ-, and δ-tomatine and tomatidine against human breast (MDA-MB-231), gastric (KATO-III), and prostate (PC3) cancer cells. J Agric Food Chem. 60: 3891-3899, 2012.
11. Collins AR, Dusinská M, Gedik CM, Stětina R. Oxidative damage to DNA: do we have a reliable biomarker? Environ Health Perspect. 104(Suppl 3): 465-469, 1996.
12. Erlacher M, Michalak EM, Kelly PN, Labi V, Niederegger H, Coultas L, Adams JM, Strasser A. Villunger A. BH3-only proteins Puma and Bim are rate limiting for gamma-radiation-and glucocorticoid-induced apoptosis of lymphoid cells in vivo. Blood. 106: 4131-4138, 2005.
13. Filderman RB, Kovacs BA. Anti-inflammatory activity of the steroid alkaloid glycoside, toatine. Br J Pharmacol. 37: 748-755, 1969.
14. Fontaine TD, Irwing GW, Ma R, Poole JB, Doolittle SP. Isolation and partial characterization of crystalline tomatine, an antibiotic agent from the tomato plant. Arch Biochem. 18: 467-475, 1948.
15. Friedman M. Tomato glycoalkaloids: role in the plant and in the diet. J Agric Food Chem. 50: 5751-5780, 2002.
16. Friedman M, Levin CE, Lee SU, Kim HJ, Lee IS, Byun JO, Kozukue N. Tomatine-containing green tomato extracts inhibit growth of human breast, colon, liver, and stomach cancer cells. J Agric Food Chem. 57: 5727-5733, 2009.
17. Fuchs Y, Steller H. Programmed cell death in animal development and disease. Cell. 147: 742-758, 2011.
18. Irwing GW, Fontaine TD, Doolittle SP. Partial Antibiotic Spectrum of Tomatin, an Antibiotic Agent from the Tomato Plant. J Bacteriol. 52: 601-607, 1946.
19. Keukens EA, de Vrije T, van den Boom C, de Waard P, Plasman HH, Thiel F, Chupin V, Jongen WM, de Kruijff B. Molecular basis of glycoalkaloid induced membrane disruption. Biochim Biophys Acta. 1240: 216-228, 1995.
20. Keukens EA, de Vrije T, Jansen LA, de Boer H, Janssen M, de Kroon AI, Jongen WM, de Kruijff B. Glycoalkaloids selectively permeabilize cholesterol containing biomembranes. Biochim Biophys Acta. 1279: 243-250, 1996.
21. Lakin ND, Jackson SP. Regulation of p53 in response to DNA damage. Oncogene. 18: 7644-7655, 1999.
22. Lavin MF, Gueven N. The complexity of p53 stabilization and activation. Cell Death Differ. 13: 941-950, 2006.
23. Lee KR, Kozukue N, Han JS, Park JH, Chang EY, Baek EJ, Chang JS, Friedman M. Glycoalkaloids and metabolites inhibit the growth of human colon (HT29) and liver (HepG2) cancer cells. J Agric Food Chem. 19: 2832-2839, 2004.
24. Lee ST, Wong PF, Cheah SC, Mustafa MR. Alphatomatine induces apoptosis and inhibits nuclear factor-kappa B activation on human prostatic adenocarcinoma PC-3 cells. PLoS One. 6: e18915, 2011.
25. Ma R, Fontaine TD. In vitro antibiotic activity of crystalline tomatine toward Candida albicans; antagonistic effect of rutin and quercetin. Arch Biochem. 16: 399-402, 1948.
26. Olive PL, Banáth JP. Detection of DNA double-strand breaks through the cell cycle after exposure to X-rays, bleomycin, etoposide and 125IdUrd. Int J Radiat Biol. 64: 349-358, 1993.
27. Prives C, Hall PA. The p53 pathway. J. Pathol. 187: 112-126, 1999.
28. Shi MD, Shih YW, Lee YS, Cheng YF, Tsai LY. Suppression of 12-O-Tetradecanoylphorbol-13-Acetate-Induced MCF-7 Breast Adenocarcinoma Cells Invasion/Migration by α-Tomatine Through Activating PKCα/ERK/NF- κB-Dependent MMP-2/MMP-9 Expressions. Cell Biochem Biophys. 2012 Nov 1. [Epub ahead of print].
29. Shieh JM, Cheng TH, Shi MD, Wu PF, Chen Y, Ko SC, Shih YW. α-Tomatine Suppresses Invasion and Migration of Human Non-Small Cell Lung Cancer NCI-H460 Cells through Inactivating FAK/PI3K/Akt Signaling Pathway and Reducing Binding Activity of NF-κB. Cell Biochem Biophys. 60: 297-310, 2011.
30. Shieh SY, Ikeda M, Taya Y, Prives C. DNA damage induced phosporylation of p53 alleviates inhibition by MDM2. Cell. 91: 325-334, 1997.
31. Shih YW, Shieh JM, Wu PF, Lee YC, Chen YZ, Chiang TA. α-Tomatine inactivates PI3K/Akt and ERK signaling pathways in human lung adenocarcinoma A549 cells: effect on metastasis. Food Chem Toxicol. 47: 1985-1995, 2009.
32. Sionov RV, Haupt Y. The cellular response to p53: the decision between life and death. Oncogene. 18: 6145-6157, 1999.
33. Taylor WR, Stark GR. Regulation of the G2/M transition by p53. Oncogene. 20: 1803-1815, 2001.
34. Tichý A, Záskodová D, Rezácová M, Vávrová J, Vokurková D, Pejchal J, Vilasová Z, Cerman J, Osterreicher J. Gamma-radiation-induced ATM-dependent signalling in human T-lymphocyte leukemic cells, MOLT-4. Acta Biochim Pol. 54: 281-287, 2007.
35. Wilson RH, Poley GW, De Eds F. Some pharmacologic and toxicologic properties of tomatine and its derivatives. Toxicol Appl Pharmacol. 3: 39-48, 1961.
36. 392 phosphorylation regulates the oncogenic function of mutant p53. Cancer Rest. 64: 4749-4754, 2004.